Literature DB >> 26613934

Case-control study on association of peroxisome proliferator-activated receptor-δ and SNP-SNP interactions with essential hypertension in Chinese Han population.

Yubo Li1, Guoqiang Sun2.   

Abstract

The aim of this study was to investigate the association of peroxisome proliferator-activated receptor-δ (PPAR-δ) and additional SNP-SNP interaction with essential hypertension (EH) in Chinese Han population. A total of 1248 subjects (625 males, 623 females), including 620 EH patients and 628 normotension subjects, were included in the study. The mean age was 51.2 ± 15.1 years old. Logistic regression model was used to examine the association between four SNP and EH; odds ratio (OR) and 95% confident interval (95%CI) were calculated. Generalized multifactor dimensionality reduction (GMDR) was employed to analyze SNP-SNP interaction. EH risk was significantly lower in carriers of C allele of the rs2016520 polymorphism than those with TT (TC + CC versus TT, adjusted OR (95%CI) = 0.61 (0.49-0.78)). In addition, we also found a significant association between rs9794 and EH; EH risk was also significantly lower in carriers of G allele of the rs9794 polymorphism than those with CC (CG + GG versus CC, adjusted OR (95%CI) = 0.65 (0.53-0.83)). We also found a potential SNP-SNP interaction between rs2016520 and rs9794; subjects with TC or CC of rs2016520 and CG or GG of rs9794 genotype have the lowest EH risk, compared to subjects with TT of rs2016520 and CC of rs9794 genotype; OR (95%CI) was 0.32 (0.23-0.62) after covariate adjustment. Our results support an important association between rs2016520 and rs9794 minor allele of PPAR-δ and decreased risk of EH and additional interaction between rs2016520 and rs9794.

Entities:  

Keywords:  Essential hypertension; Interaction; PPAR-δ; Polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26613934     DOI: 10.1007/s10142-015-0469-5

Source DB:  PubMed          Journal:  Funct Integr Genomics        ISSN: 1438-793X            Impact factor:   3.410


  21 in total

1.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

Review 2.  The search for the genetic basis of hypertension.

Authors:  Yoram Yagil; Chana Yagil
Journal:  Curr Opin Nephrol Hypertens       Date:  2005-03       Impact factor: 2.894

3.  Haplotype analysis of PPARγ C681G and intron CT variants. Positive association with essential hypertension.

Authors:  Q Zhu; Z Guo; X Hu; M Wu; Q Chen; W Luo; J Liu
Journal:  Herz       Date:  2013-05-09       Impact factor: 1.443

4.  Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity.

Authors:  Yong-Xu Wang; Chih-Hao Lee; Sambath Tiep; Ruth T Yu; Jungyeob Ham; Heonjoong Kang; Ronald M Evans
Journal:  Cell       Date:  2003-04-18       Impact factor: 41.582

5.  [PPARdelta + 294T/C gene polymorphism related to plasma lipid, obesity and left ventricular hypertrophy in subjects with metabolic syndrome].

Authors:  Zhen-cheng Yan; Cheng-yi Shen; Jian Zhong; Ling Wang; Yin-xing Ni; Hai Nie; Zhi-ming Zhu
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2005-06

6.  Association of peroxisome proliferator-activated receptor γ polymorphisms and haplotypes with essential hypertension.

Authors:  Shu-Jun Gu; Zhi-Rong Guo; Ming Wu; Yi Ding; Wen-Shu Luo
Journal:  Genet Test Mol Biomarkers       Date:  2013-03-26

7.  [Association between peroxisome proliferator-activated receptors gene polymorphism and essential hypertension].

Authors:  Yao Lin; Shu-jun Gu; Ming Wu; Qiu Chen; Zheng-yuan Zhou; Hao Yu; Li-jun Zhang; Wen-shu Luo; Zhi-rong Guo
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2012-06

8.  Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome.

Authors:  Toshiya Tanaka; Joji Yamamoto; Satoshi Iwasaki; Hiroshi Asaba; Hiroki Hamura; Yukio Ikeda; Mitsuhiro Watanabe; Kenta Magoori; Ryoichi X Ioka; Keisuke Tachibana; Yuichiro Watanabe; Yasutoshi Uchiyama; Koichi Sumi; Haruhisa Iguchi; Sadayoshi Ito; Takefumi Doi; Takao Hamakubo; Makoto Naito; Johan Auwerx; Masashi Yanagisawa; Tatsuhiko Kodama; Juro Sakai
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

9.  Association of several lipid-related gene polymorphisms and blood pressure variation in the Bai Ku Yao population.

Authors:  Rui-Xing Yin; Jin-Zhen Wu; Wan-Ying Liu; Dong-Feng Wu; Xiao-Li Cao; Lin Miao; Lynn Htet Htet Aung; Lin Zhang; Xing-Jiang Long; Meng Li; Shang-Ling Pan
Journal:  Am J Hypertens       Date:  2012-05-10       Impact factor: 2.689

10.  Antihypertensive effects of peroxisome proliferator-activated receptor-β activation in spontaneously hypertensive rats.

Authors:  María José Zarzuelo; Rosario Jiménez; Pilar Galindo; Manuel Sánchez; Ana Nieto; Miguel Romero; Ana María Quintela; Rocío López-Sepúlveda; Manuel Gómez-Guzmán; Elvira Bailón; Isabel Rodríguez-Gómez; Antonio Zarzuelo; Julio Gálvez; Juan Tamargo; Francisco Pérez-Vizcaíno; Juan Duarte
Journal:  Hypertension       Date:  2011-08-08       Impact factor: 9.897

View more
  1 in total

1.  Associations between hypertension and the peroxisome proliferator-activated receptor-δ (PPARD) gene rs7770619 C>T polymorphism in a Korean population.

Authors:  Minjoo Kim; Minkyung Kim; Hye Jin Yoo; Jayoung Shon; Jong Ho Lee
Journal:  Hum Genomics       Date:  2018-06-18       Impact factor: 4.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.